Jovanny Garcia Garcia, 30, is charged with one count of intentional child abuse resulting in injury. This is a class 2 felony ...
Scientists have discovered how to electrically power insulating nanoparticles using organic molecules that act like tiny ...
Multiple long-term follow-up studies confirm BRUKINSA’s superior efficacy and favorable tolerability versus ibrutinib in relapsed or refractory CLLAdditional ASH data from investigational BTK degrader ...
ORLANDO -- For triple-class exposed relapsed or refractory multiple myeloma with extramedullary disease (EMD), a combination of talquetamab (Talvey) and teclistamab (Tecvayli) achieved high response ...
The Bears’ five-game winning streak is over following a heartbreaker in Green Bay. Now is not the time to panic, says ...
Wave Life Sciences Ltd. ( WVE) Discusses Positive Interim Data from INLIGHT Trial of WVE-007 for Obesity December 8, 2025 8:30 AM EST ...
Following a single subcutaneous 240 mg dose, WVE-007 (INHBE GalNAc-siRNA) improved body composition at three months compared ...
-- ImCheck Reports Durable Responses and Early Overall Survival Signal with ICT01 in First-line AML at ASH 2025 -- ...
Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time ...
Alpha-9 Oncology, a clinical-stage radiotherapeutic company developing targeted cancer therapies, today announced the initiation of dosing in a Phase 1 study evaluating A9-3408, a novel ...
Coherus Oncology, Inc. (NASDAQ: CHRS) today announced compelling six-year overall survival (OS) follow-up results from the Phase 3 JUPITER-02 trial evaluating LOQTORZI® (toripalimab-tpzi) plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback